Amrita Institute of Medical Sciences | ClinicalTrials HQ

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, anemia, bone marrow disorder, hematologic disorder, primary myelofibrosis	Recruiting	Phase 3	2026-10-01		NCT07623161
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease	Moderately to Severely Active Crohns Disease	Recruiting	Phase 3	2026-09-28		NCT06819891
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease	Moderately to Severely Active Crohns Disease	Recruiting	Phase 3	2026-09-16		NCT06819878
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, heart disorder, heart failure, nutritional disorder, obesity disorder, overnutrition	Recruiting	Phase 3	2026-08-18		NCT07567001
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 4	2026-07-06		NCT05348876
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, ovarian serous adenocarcinoma, peritoneal carcinoma	Active, not recruiting	Phase 2	2026-04-01		NCT05605535
ICU-related Out of Pocket Expenses (ICOPE)	Cost of ICU; Out of Pocket Expenses	Recruiting	Not stated	2026-02-27		NCT07439692
International Registry of Congenital Portosystemic Shunt (IRCPSS)	46,XX disorder of sex development, Brain Diseases, Metabolic, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hepatic Insufficiency, Hyperammonemia, Hyperandrogenism, Insulin Resistance, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, Urogenital Abnormalities, Urogenital Diseases, adrenogenital syndrome, brain disorder, cardiovascular disorder, central nervous system disorder, congenital portosystemic shunt, disorder of sexual differentiation, endocrine system disorder, glucose metabolism disease, gonadal disorder, hepatic encephalopathy, hepatopulmonary syndrome, hyperinsulinism, hypertensive disorder, hypoglycemia, liver disorder, liver failure, lung disorder, metabolic disease, neoplasm, nervous system disorder, pulmonary hypertension, respiratory system disorder, vascular disorder, vascular malformation	Enrolling by invitation	Not stated	2025-06-18		NCT06041906